• Version
• Download 627
• File Size 286.20 KB
• File Count 1
• Create Date March 20, 2023
• Last Updated March 20, 2023

Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication (1 of 2022/2023)

Through one of its committees, the Pharmacovigilance Experts Review and Advisory Committee (PERAC), the Pharmacovigilance division conducted a causality assessment of the serious cases suspected to have been caused by some anti-tuberculosis medicines received at the Board and wishes to make recommendations for healthcare professionals on Anti-Tuberculosis Medication.

Attached Files